68.0
[]. A M Upton, et al. In vitro and in vivo activities of the nitroimidazole TBA-54 against Mycobacterium tuberculosis. Antimicrob Agents Chemother. 05 Jan;5():6-44.
[]. C Hochfellner, et al. Antagonistic effects of indoloquinazoline alkaloids on antimycobacterial activity of evocarpine. J Appl Microbiol. 05 Apr;8(4):864-7.
[]. Denis Fourches, et al. Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chem Res Toxicol. 00 Jan;():7-8.
[4]. Gerjo J de Knegt, et al. Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy. Tuberculosis (Edinb). 04 Dec;4(6):70-7.
[5]. Kushal Garima, et al. Differential expression of efflux pump genes of Mycobacterium tuberculosis in response to varied subinhibitory concentrations of antituberculosis agents. Tuberculosis (Edinb). 05 Mar;5():55-6.
H0
P6-P64-P70-P7-P80-P0+P5-P04+P40-P05+P5+P8-P0-P6+P64-P40+P-P405-P50
077